Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib
- 1 February 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 17 (2) , 465-467
- https://doi.org/10.1038/sj.leu.2402791
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hematopathologic and cytogenetic findings in imatinib mesylate–treated chronic myelogenous leukemia patients: 14 months' experienceBlood, 2002
- Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8Leukemia, 2002
- Spotlight Imatinib: a model for signal transduction inhibitorsLeukemia, 2002
- Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II studyBlood, 2002
- Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyBlood, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002